Form 4: Sangamo Therapeutics CFO Disposes of Shares for Tax Withholding
SEC Form 4 Filing
Prathyusha Duraibabu, CFO of Sangamo Therapeutics, disposed of shares to cover tax obligations related to vesting restricted stock units (RSUs).
Summary
- Prathyusha Duraibabu, the SVP and CFO of Sangamo Therapeutics, disposed of 5,474 shares of common stock on February 24, 2024, and 3,453 shares on February 25, 2024, at a price of $1.13 per share.
- These transactions were not discretionary trades but were solely for mandatory tax withholding purposes related to the vesting of RSU grants.
- Following these transactions, Duraibabu beneficially owns 838,031 shares and 834,578 shares respectively.
- The vesting of the RSU grants is subject to Duraibabu's continuous service with the company.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions for tax purposes; it doesn't inherently convey positive or negative sentiment.
Future Outlook
The CFO's remaining RSU grants will continue to vest in installments over the coming years, contingent on continued service.
Industry Context
Form 4 filings are routine disclosures for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor dilutive effect on existing shareholders due to the issuance of shares for RSU vesting.
- The transactions ensure compliance with tax regulations.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Date of RSU grant that will vest in one final installment on February 25, 2024 |
| 02/25/2022 | Date of RSU grant that will vest in successive equal quarterly installments through February 25, 2025 |
| 02/24/2023 | Date of RSU grant that will vest in successive equal quarterly installments through February 24, 2026 |
| 01/22/2024 | Date of RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter. |
| 02/24/2024 | Date of transaction where 5,474 shares were disposed of for tax withholding. |
| 02/25/2024 | Date of transaction where 3,453 shares were disposed of for tax withholding. |
| 02/27/2024 | Date of signature on the Form 4 filing. |
| 06/11/2024 | Date of RSU grant that will vest in one final installment on June 11, 2024 |
| 02/24/2026 | Date of final vesting installment of the Reporting Person's February 24, 2023 RSU grant |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.